Overview
- 23 inspections across 23 sites are on record.
- 53 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-04.
At a glance
Inspections
23
Sites
23
Observations
53
Career since
Apr 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Bachem Americas, Inc. | 4 May 2026 | Human Drugs | On file |
| Pyramid Laboratories, Inc. | 13 Feb 2026 | Human Drugs | On file |
| Exela Pharma Sciences, LLC. | 15 Nov 2024 | Human Drugs | On file |
| TG Labs, Inc. | 17 Jun 2024 | Human Drugs | On file |
| Genentech, Inc. | 19 Apr 2024 | Human Drugs | On file |
Sites inspected
Bachem Americas, Inc.Torrance, United States1 insp.
Pyramid Laboratories, Inc.Costa Mesa, United States1 insp.
Exela Pharma Sciences, LLC.Lenoir, United States1 insp.
TG Labs, Inc.Centennial, United States1 insp.
Genentech, Inc.Hillsboro, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sangeeta M Khurana5 shared
Alan L Truong3 shared
Navneet Kaur2 shared
Cecilia H Kieu2 shared
Santos E Camara2 shared
Vioela J Caze2 shared
Marian E Ramirez2 shared
Vilmary Negron Rodriguez2 shared
Aranjeet Singh1 shared
Gloria E Andia1 shared
Full investigator report
Get the verbatim findings behind Joan M Cantellops Figueroa's 53 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site